← Leaderboards
Qiang Li
Roswell Park Cancer Institute Corp
$1,428,645
Attributed
$1,428,645
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $285.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,428,645 · 1
By mechanism
K08$1,428,645 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Li Tang$8,006,573
- Leigh Ellis$3,518,676
- Meenalakshmi Chinnam$651,060
- Mukund Seshadri$11,493,912
- Alyssa Ione Clay-Gilmour$1,711,362
Others in their field
Other Emerging Leaders on “Chemotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Olwen Hahn · Brigham And Women'S Hospital$13,557,463
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Jessica Scott · Sloan-Kettering Inst Can Research$7,160,357
- Vera Hoffman · Reveal Pharma$6,103,452
Research focus
ChemotherapyClinically RelevantCharacteristicsAnalysis PipelineAdenovirusesCisplatinBasal CellAcquired Drug ResistanceBioinformaticsBiologicalBladderBladder NeoplasmBladder UrotheliumCancer BiologyCancer CellCancer ModelCancer PatientCancer SubtypesCancer TypeCareerCareer DevelopmentCell Cycle RegulationCellsClinical Research
Grant awards (5)
Therapeutic implication of RB1 loss in bladder cancer$285,729
K08 · FY2025 · CA · contact PI
Therapeutic implication of RB1 loss in bladder cancer$285,729
K08 · FY2024 · CA · contact PI
Therapeutic implication of RB1 loss in bladder cancer$285,729
K08 · FY2023 · CA · contact PI
Therapeutic implication of RB1 loss in bladder cancer$285,729
K08 · FY2022 · CA · contact PI
Therapeutic implication of RB1 loss in bladder cancer$285,729
K08 · FY2021 · CA · contact PI